Dudediligence.

AIM ImmunoTech Inc

AIMAMEX · Biological Products, (No Diagnostic Substances)
Write an idea

Price
FilingsNewest: 8-K, Material agreementSep 14 →InsidersNo open-market buys or sales.→HoldersJane Street 2.8%Morgan Stanley 0.2%Geode 0.2%→Financing →PeersClosest companies: IMNN, SNGX, GALT→

From the filings

Figures

Revenue
$95,000last 12 months
Net income
−$14.3Mlast 12 months
Operating cash flow
−$11.3Mlast 12 months
Cash and equivalents
$9.9Mat the last balance sheet
Total debt
$7.2Mat the last balance sheet
Shares outstanding
29.0M shareson issue
Every year and quarter →